Cargando…
Update of a comparative analysis of cost minimization following the introduction of newly available intravenous iron therapies in hospital practice
BACKGROUND: The clinical need to be able to administer high doses of intravenous iron conveniently as a rapid infusion has been addressed by the recent introduction of ferric carboxymaltose and subsequently iron isomaltoside 1000. Neither requires a test dose. The maximum dose of ferric carboxymalto...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253757/ https://www.ncbi.nlm.nih.gov/pubmed/22241947 http://dx.doi.org/10.2147/TCRM.S25882 |